Correlation Between Pharvaris and Sirona Biochem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Sirona Biochem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Sirona Biochem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Sirona Biochem Corp, you can compare the effects of market volatilities on Pharvaris and Sirona Biochem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Sirona Biochem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Sirona Biochem.

Diversification Opportunities for Pharvaris and Sirona Biochem

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pharvaris and Sirona is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Sirona Biochem Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sirona Biochem Corp and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Sirona Biochem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sirona Biochem Corp has no effect on the direction of Pharvaris i.e., Pharvaris and Sirona Biochem go up and down completely randomly.

Pair Corralation between Pharvaris and Sirona Biochem

Given the investment horizon of 90 days Pharvaris BV is expected to generate 0.65 times more return on investment than Sirona Biochem. However, Pharvaris BV is 1.53 times less risky than Sirona Biochem. It trades about -0.1 of its potential returns per unit of risk. Sirona Biochem Corp is currently generating about -0.08 per unit of risk. If you would invest  2,125  in Pharvaris BV on September 12, 2024 and sell it today you would lose (244.50) from holding Pharvaris BV or give up 11.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  Sirona Biochem Corp

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Pharvaris is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Sirona Biochem Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sirona Biochem Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Sirona Biochem reported solid returns over the last few months and may actually be approaching a breakup point.

Pharvaris and Sirona Biochem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and Sirona Biochem

The main advantage of trading using opposite Pharvaris and Sirona Biochem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Sirona Biochem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sirona Biochem will offset losses from the drop in Sirona Biochem's long position.
The idea behind Pharvaris BV and Sirona Biochem Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Transaction History
View history of all your transactions and understand their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum